Brief: Crescita Secures Contract Manufacturing Revenue Of $10 Mln Over 4 Years
22/07/2024 13:00
July 22 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA SECURES CONTRACT MANUFACTURING REVENUE OF $US10
MILLION
OVER 4 YEARS
Source text for Eikon: ID:nBwrHRCna
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium